189 related articles for article (PubMed ID: 38087889)
41. Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells.
Mongiardi MP
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):878-83. PubMed ID: 23131159
[TBL] [Abstract][Full Text] [Related]
42. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
43. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
Jung N; Kwon HJ; Jung HJ
Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404
[TBL] [Abstract][Full Text] [Related]
45. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
46. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
[TBL] [Abstract][Full Text] [Related]
47. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
48. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
[TBL] [Abstract][Full Text] [Related]
49. Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions.
Cheng Y; Li S; Hou Y; Wan W; Wang K; Fu S; Yuan Y; Yang K; Ye X
Cell Signal; 2023 Sep; 109():110754. PubMed ID: 37315748
[TBL] [Abstract][Full Text] [Related]
50. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
[TBL] [Abstract][Full Text] [Related]
51. Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.
Patyka M; Sharifi Z; Petrecca K; Mansure J; Jean-Claude B; Sabri S
Oncotarget; 2016 Sep; 7(37):60245-60269. PubMed ID: 27533246
[TBL] [Abstract][Full Text] [Related]
52. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract][Full Text] [Related]
53. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
54. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.
Liu TZ; Wang X; Bai YF; Liao HZ; Qiu SC; Yang YQ; Yan XH; Chen J; Guo HB; Zhang SZ
Int J Biochem Cell Biol; 2014 Apr; 49():8-16. PubMed ID: 24434023
[TBL] [Abstract][Full Text] [Related]
55. Transgelin overexpression in lung adenocarcinoma is associated with tumor progression.
Wu X; Dong L; Zhang R; Ying K; Shen H
Int J Mol Med; 2014 Aug; 34(2):585-91. PubMed ID: 24938684
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells.
Luo M; Liu YQ; Zhang H; Luo CH; Liu Q; Wang WY; He ZC; Chen C; Zhang XN; Mao M; Yang KD; Wang C; Chen XQ; Fu WJ; Niu Q; Bian XW; Shi Y; Ping YF
Lab Invest; 2022 Jul; 102(7):722-730. PubMed ID: 34963686
[TBL] [Abstract][Full Text] [Related]
57. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
Li Z; Bao S; Wu Q; Wang H; Eyler C; Sathornsumetee S; Shi Q; Cao Y; Lathia J; McLendon RE; Hjelmeland AB; Rich JN
Cancer Cell; 2009 Jun; 15(6):501-13. PubMed ID: 19477429
[TBL] [Abstract][Full Text] [Related]
58. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
[TBL] [Abstract][Full Text] [Related]
59. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
[TBL] [Abstract][Full Text] [Related]
60. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]